Yorktown Management & Research Company’s NeoGenomics NEO Stock Holding History

Yorktown Management & Research Company’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26,600	Closed	-$908K	–	248
2021 Q4	$908K	Buy	26,600 +2,000	+8%	+$78.3K	0.61%	32
2021 Q3	$1.19M	Hold	24,600	–	–	0.89%	12
2021 Q2	$1.11M	Buy	24,600 +700	+3%	+$31K	0.87%	15
2021 Q1	$1.15M	Buy	23,900 +3,100	+15%	+$161K	0.96%	14
2020 Q4	$1.12M	Sell	20,800 -1,200	-5%	-$54.2K	1.01%	14
2020 Q3	$812K	Buy	22,000 +3,000	+16%	+$112K	0.76%	19
2020 Q2	$589K	Hold	19,000	–	–	0.53%	27
2020 Q1	$525K	Hold	19,000	–	–	0.53%	53
2019 Q4	$556K	Buy	19,000 +700	+4%	+$16.7K	0.3%	117
2019 Q3	$350K	Hold	18,300	–	–	0.19%	149
2019 Q2	$402K	Buy	18,300 +800	+5%	+$17.6K	0.15%	172
2019 Q1	$358K	Hold	17,500	–	–	0.12%	206
2018 Q4	$221K	Buy	+17,500	New	+$261K	0.07%	296

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Yorktown Management & Research Company's NEO Position: Q1 2022 in Review

Yorktown Management & Research Company sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 26,600 shares — an estimated $908K sold.

Yorktown Management & Research Company first reported a position in NEO in Q4 2018 and held it in 13 quarters. The position peaked at $1.19M in Q3 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

Yorktown Management & Research Company reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
Yorktown Management & Research Company sold 26,600 NeoGenomics shares in Q1 2022, an estimated $908K.
Yorktown Management & Research Company first reported a position in NeoGenomics in Q4 2018 and held it in 13 quarters.
Yorktown Management & Research Company's NeoGenomics position peaked at $1.19M in Q3 2021.
280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Yorktown Management & Research Company's 13F filing for Q1 2022, filed 29 Apr 2022.